TechNation Radio Podcast

On this week’s Tech Nation, Moira speaks with
Stanford Professors, Bob Sutton and Huggy Rao, talk about their book, “The Friction Project: How Smart Leaders Make the Right Things Easier and the Wrong Things Harder.” Then, is your personal technology doing more than you bargained for? Duke University Professor Nita Farahany talks about “The Battle for Your Brain … Defending the Right to Think Freely in the Age of Neurotechnology.”

On this week’s Tech Nation, Moira speaks with Stanford Professors, Bob Sutton and Huggy Rao, talk about their book, “The Friction Project: How Smart Leaders Make the Right Things Easier and the Wrong Things Harder.” Then, is your personal technology doing more than you bargained for? Duke University Professor Nita Farahany talks about “The Battle for Your Brain … Defending the Right to Think Freely in the Age of Neurotechnology.”

On this week’s Tech Nation, Moira speaks with
Journalist and CEO of Global Press, Christi Hegranes, talks about her vision of what it really means to have a global press and her book, “Byline: How Local Journalists Can Improve the Global News Industry and Change the World.”  Then, Alex Pang, a regular contributor for Tech Nation and author of, ”Rest: Why You Get More Work Done, When You Work Less” tells us how a Four-Day Work Week can work, and Dr. Jim Brown, CEO of DURECT, talks about their clinical trials for Alcohol-Associated Hepatitis.

On this week’s Tech Nation, Moira speaks with
Journalist and CEO of Global Press, Christi Hegranes, talks about her vision of what it really means to have a global press and her book, “Byline: How Local Journalists Can Improve the Global News Industry and Change the World.”  Then, Alex Pang, a regular contributor for Tech Nation and author of, ”Rest: Why You Get More Work Done, When You Work Less” tells us how a Four-Day Work Week can work, and Dr. Jim Brown, CEO of DURECT, talks about their clinical trials for Alcohol-Associated Hepatitis.

On this week’s Tech Nation, Moira speaks with Science Journalist Ben Goldfarb about his book, “Crossing: How Road Ecology is Shaping the Future of our Planet.” Then, Dave Pacitti, President of Siemens Healthineers, sets out to solve problems greater than simply supplying the best technology.

On this week’s Tech Nation, Moira speaks with Science Journalist Ben Goldfarb about his book, “Crossing: How Road Ecology is Shaping the Future of our Planet.” Then, Dave Pacitti, President of Siemens Healthineers, sets out to solve problems greater than simply supplying the best technology.

On this week’s Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma, about its approach to Acute Myeloid Leukemia, also known as AML. Then, Dr. Nik Sopko, the chief scientific officer of PolarityTE, talked about their design for wound healing. Their first treatment candidate is diabetic foot ulcers, and Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.

On this week’s Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma about its approach to Acute Myeloid Leukemia, also known as AML. Then, Dr. Nik Sopko, the chief scientific officer of PolarityTE, talked about their design for wound healing. Their first treatment candidate is diabetic foot ulcers and Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.

On this week’s Tech Nation, Moira speaks with Dr. Stewart Campbell, CEO of Axial Therapeutics, about their groundbreaking work in Autism–related irritability in teenagers, in Parkinson’s, and in complementing the latest cancer treatments. Then Dr. Ray Stevens, CEO of ShouTi Pharma, talks about their approach in turning IV drugs into pills. Current projects include Diabetes and obesity and two Pulmonary and Cardiovascular disorders. And these are just their first candidates …

On this week’s Tech Nation, Moira speaks with Dr. Stewart Campbell, CEO of Axial Therapeutics, about their groundbreaking work in Autism–related irritability in teenagers, in Parkinson’s, and in complementing the latest cancer treatments. Then Dr. Ray Stevens, CEO of ShouTi Pharma, talks about their approach in turning IV drugs into pills. Current projects include Diabetes and obesity and two Pulmonary and Cardiovascular disorders. And these are just their first candidates …